高瓴重倉領域——港股生物醫藥股全線下跌

格隆匯
2021.08.12 07:26
騰盛博藥-B 跌超 13%，諾誠健華-B 跌超 11%，康希諾生物、泰格醫藥和榮昌生物-B 跌超 7%，加科思-B、百濟神州、康諾亞-B 跌超 6%，科濟藥業-B 跌 5%，方達控股、沛嘉醫療-B 跌超 4%，啓明醫療-B、藥明康德和藥明巨諾-B 跌超 3%。生物醫藥是高瓴的重倉領域，有數據顯示，高瓴目前在全球醫療健康產業中已投資 200 餘家企業，其中，國內企業 100 餘家。注：2020 年 9 月 1 日，在 2020 香港交易所生物科技峯會中，高瓴創始人張磊曾表示，高瓴在生物醫藥行業投資了 1200 億元。
Source: 格隆匯 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.